Showing 1 - 14 of 14 results
Public Interest Disclosure Scheme
The Public Interest Disclosure Act 2013 aims to promote integrity and accountability in the Australian Public Sector by encouraging the disclosure of information about actual or suspected wrongdoing, protecting people who make disclosures and ensuring that disclosures are properly investigated and dealt with.
Privacy Policy
Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.
Application Process
On this page you will find useful information about applying for a position at ANSTO and some tips on how you can prepare for an interview.
A look back at the monumental achievement of constructing the OPAL reactor
INVAP, the Argentinian advanced nuclear technology company, who designed and constructed the Open Pool Lightwater Reactor (OPAL) for ANSTO to replace the HIFAR reactor is celebrating 50 years of operations with the visit of a group of INVAP executives to ANSTO to celebrate their achievements and discuss future collaborations.
National medical facility to triple production of radiopharmaceuticals
Fossils go nuclear
Beamline Proposal & Experiment Guide
Guide to successful proposals and experiments at the Powder Diffraction beamline.
TSPO: Ancient gene ignites potential for drug development
Small Modular Reactors: An overview
Advanced Diffraction & Scattering Beamlines (ADS-1 and ADS-2) UNDER CONSTRUCTION
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
Role at ANSTO
High Performance Macromolecular Crystallography Beamline (MX3)
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.